| Organism name | Vicia faba | 
|---|---|
| Genus | Vicia | 
| Family | Fabaceae | 
| Kingdom | Plantae | 
| Linked NCBI taxonomy name | Vicia faba | 
|---|---|
| Linked NCBI taxonomy ID | 3906 | 
| Linked level | species | 
| Family in NCBI taxonomy | Fabaceae | 
|---|---|
| ID | 3803 | 
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae | 
|---|---|
| ID | 33090 | 
| Plant class | rosids | 
|---|---|
| ID | 71275 | 
| KNApSAcK ID | name | ChEMBL link | CTD link | # of proteins in ChEMBL interaction / related OMIM / related KEGG DISEASE | # of genes in CTD interaction / related diseases | KCF-S cluster | phytochemical cluster | figure | 
|---|---|---|---|---|---|---|---|---|
| C00007247   | Linolenic acid / alpha-Linolenic acid / (Z,Z,Z)-Octadeca-9,12,15-trienoic acid | D017962 | 22 / 5 |   | ||||
| C00005981   | Quercetin 3-(6''-acetylgalactoside)-7-rhamnoside | No. 1 | No. 15 |   | ||||
| C00005888   | Kaempferol 3-(6''-acetylgalactoside)-7-rhamnoside | No. 1 | No. 15 |   | ||||
| C00005178   | Kaempferol 3-galactoside-7-rhamnoside | CHEMBL1929192 CHEMBL1929193 | 2 / 0 / 0 | No. 1 | No. 15 |   | ||
| C00005425   | Quercetin 3-galactoside-7-rhamnoside | CHEMBL592361 CHEMBL1774171 | No. 1 | No. 15 |   | |||
| C00005408   | Quercetin 3-galactosyl-(1->6)-glucoside | CHEMBL1097317 | No. 1 | No. 15 |   | |||
| C00005184   | Kaempferol 3-glucoside-7-rhamnoside | CHEMBL1929192 CHEMBL1929193 | 2 / 0 / 0 | No. 1 | No. 15 |   | ||
| C00005182   | Kaempferol 3,7-diglucoside / Kaempferol 3,7-O-beta-D-diglucopyranoside | CHEMBL2206209 | No. 1 | No. 15 |   | |||
| C00001071   | Myricetin | CHEMBL164 | C040015 | 78 / 70 / 56 | 39 / 2 | No. 3 | No. 15 |   | 
| C00005906   | Kaempferol 3-rhamnosyl-(1->2)(6''-acetylgalactoside)-7-rhamnoside | No. 5 | No. 15 |   | ||||
| C00005224   | Kaempferol 3-rhamnosyl-(1->2)-galactoside-7-rhamnoside | CHEMBL1929027 CHEMBL1926685 | 2 / 0 / 0 | No. 5 | No. 15 |   | ||
| C00009075   | Procyanidin B1 / Epicatechin-(4beta->8)-catechin | CHEMBL38714 CHEMBL81753 CHEMBL504937 CHEMBL501490 CHEMBL447373 CHEMBL1253314 CHEMBL1590914 | C479579 | 20 / 7 / 8 | No. 16 | No. 19 |   | |
| C00002935   | Procyanidin B4 / Catechin-(4alpha->8)-epicatechin | CHEMBL38714 CHEMBL81753 CHEMBL504937 CHEMBL501490 CHEMBL447373 CHEMBL1253314 CHEMBL1590914 | 20 / 7 / 8 | No. 16 | No. 19 |   | ||
| C00002923   | Prodelphinidin B4 / Gallocatechin-(4alpha->8)-epigallocatechin | CHEMBL349509 CHEMBL161013 | No. 16 | No. 19 |   | |||
| C00009111   | Prodelphinidin C | No. 16 | No. 19 |   | ||||
| C00009112   | Gallocatechin-(4alpha->8)-epicatechin | No. 16 | No. 19 |   | ||||
| C00000299   | GA98 / Gibberellin A98 | No. 40 | No. 41 |   | ||||
| C00000020   | GA20 / Gibberellin A20 | No. 40 | No. 41 |   | ||||
| C00000044   | GA44 / Gibberellin A44 | No. 40 | No. 41 |   | ||||
| C00000029   | GA29 / Gibberellin A29 | No. 40 | No. 41 |   | ||||
| C00008818   | Epigallocatechin / (-)-Epigallocatechin | CHEMBL47386 CHEMBL125743 CHEMBL130415 CHEMBL264167 CHEMBL404845 | 26 / 17 / 29 | No. 52 | No. 14 |   | ||
| C00000956   | (-)-Epicatechin | CHEMBL80941 CHEMBL311498 CHEMBL129482 CHEMBL200715 CHEMBL206452 CHEMBL583912 | 85 / 58 / 54 | No. 52 | No. 14 |   | ||
| C00000181   | Castasterone | C083545 | No. 68 | No. 11 |   | |||
| C00000180   | 24-Epibrassinolide | CHEMBL563853 CHEMBL1801925 CHEMBL1967970 | No. 68 | No. 11 |   | |||
| C00000189   | Brassinone / Norcastasterone / 28-Norcastasterone | No. 68 | No. 11 |   | ||||
| C00000192   | Dolichosterone | No. 68 | No. 11 |   | ||||
| C00000176   | Brassinolide | CHEMBL563853 CHEMBL1801925 CHEMBL1967970 | C023623 | 16 / 2 | No. 68 | No. 11 |   | |
| C00003825   | 3',4',7-Trihydroxyflavone / 7,3',4'-Trihydroxyflavone | CHEMBL301624 | 4 / 5 / 5 | No. 71 | No. 15 |   | ||
| C00003800   | 7,4'-Dihydroxyflavone | CHEMBL294878 | C085172 | 17 / 19 / 16 | No. 76 | No. 15 |   | |
| C00000019   | GA19 / Gibberellin A19 | C120175 | No. 187 | No. 41 |   | |||
| C00000053   | GA53 / Gibberellin A53 | No. 187 | No. 41 |   | ||||
| C00000225   | 9,10-Dihydrojasmonic acid | No. 707 | No. 70 |   | ||||
| C00000218   | Jasmonic acid / trans-Jasmonic acid / 3-Oxo-2-(2Z-pentenyl)cyclotentylacetic acid | CHEMBL445499 CHEMBL449572 | C011006 | 4 / 1 / 0 | No. 707 | No. 70 |   | |
| C00000362   | OPC-6:0 | No. 707 | No. 70 |   | ||||
| C00000134   | (s)-(+)-Abscisic acid / 2,4-Pentadienoic acid | CHEMBL288040 CHEMBL379808 CHEMBL1318134 CHEMBL1469719 CHEMBL1741460 CHEMBL1965138 | D000040 | 10 / 9 / 10 | No. 1435 | No. 38 |   | |
| C00011540   | Nigellic acid | CHEMBL396834 | No. 1435 | No. 38 |   | |||
| C00001357   | L-Dopa | CHEMBL1009 CHEMBL351042 CHEMBL211670 | 140 / 68 / 62 | No. 1584 |   | |||
| C00001145   | Raffinose | CHEMBL175500 CHEMBL603717 | D011887 | No. 1765 |   | |||
| C00001518   | L-Glutathione | CHEMBL100476 CHEMBL1543 CHEMBL1514919 | D005978 | 12 / 17 / 16 | 119 / 45 | No. 3357 |   | |
| C00000447   | 4-Hydroxy-2E-nonenal | CHEMBL454280 | 4 / 7 / 6 | No. 3536 |   | |||
| C00001201   | Quinic acid | CHEMBL444501 CHEMBL465398 | D011801 | 5 / 1 / 3 | No. 3541 |   | ||
| C00001183   | Fumaric acid | CHEMBL503160 CHEMBL539648 | C032005 | 17 / 14 / 46 | 0 / 1 | No. 3766 |   | |
| C00000103   | 4-Chloroindole-3-acetic acid methyl ester | C028267 | No. 4225 |   | ||||
| C00000102   | 4-Chloro-IAA / 4-Chloroindole-3-acetic acid | CHEMBL309993 | C096198 | 1 / 0 / 0 | No. 4225 |   | ||
| C00001515   | Vicine | C009661 | No. 4434 |   | ||||
| C00001299   | Wyerone | No. 5575 | No. 69 |   | ||||
| C00001300   | Wyerone acid | No. 5575 | No. 69 |   | ||||
| C00001431   | Spermidine | CHEMBL19612 | D013095 | 26 / 10 / 12 | 5 / 5 | No. 5867 |   | |
| C00001432   | Spermine | CHEMBL23194 | D013096 | 35 / 17 / 25 | 7 / 11 | No. 7197 |   | |
| C00001198   | Oxalic acid | CHEMBL146755 | D019815 | 2 / 0 / 0 | 1 / 6 | No. 7540 |   | 
| accession | description | class description | KNApSAcK metabolite in interactions | # of diseases (OMIM / KEGG) | 
|---|---|---|---|---|
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000134 C00000956 C00001071 C00001357 C00001431 C00001432 C00002935 C00003800 C00009075 | 0 / 1 | 
| P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00000956 C00001071 C00001357 C00001431 C00001432 C00001518 C00002935 C00008818 C00009075 | 0 / 0 | 
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000134 C00000956 C00001071 C00001357 C00001431 C00001432 C00002935 C00009075 | 1 / 0 | 
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00000134 C00000956 C00001071 C00001357 C00001431 C00001432 C00002935 C00009075 | 0 / 0 | 
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000134 C00000956 C00001071 C00001357 C00001431 C00001432 C00002935 C00009075 | 1 / 1 | 
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000134 C00000956 C00001071 C00001357 C00001431 C00001432 C00002935 C00009075 | 0 / 1 | 
| Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00000956 C00001071 C00001357 C00001432 C00002935 C00003800 C00008818 C00009075 | 3 / 3 | 
| B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00000956 C00001071 C00001357 C00001518 C00003800 C00008818 | 0 / 0 | 
| P00918 | Carbonic anhydrase 2 | Lyase | C00000956 C00001183 C00001357 C00001431 C00001432 C00001518 | 1 / 2 | 
| P10636 | Microtubule-associated protein tau | Unclassified protein | C00000447 C00000956 C00001071 C00001357 C00001518 C00008818 | 4 / 3 | 
| Q9Y2D0 | Carbonic anhydrase 5B, mitochondrial | Lyase | C00000956 C00001183 C00001357 C00001431 C00001432 | 0 / 0 | 
| P11388 | DNA topoisomerase 2-alpha | Isomerase | C00000956 C00001071 C00005178 C00005184 C00005224 | 0 / 0 | 
| P11473 | Vitamin D3 receptor | NR1I1 | C00000447 C00000956 C00001071 C00001357 C00008818 | 2 / 3 | 
| P35218 | Carbonic anhydrase 5A, mitochondrial | Lyase | C00000956 C00001183 C00001357 C00001431 C00001432 | 0 / 0 | 
| P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00000956 C00001071 C00001357 C00001432 C00008818 | 0 / 0 | 
| P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00000956 C00001071 C00001357 C00003800 C00008818 | 2 / 2 | 
| Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00000956 C00001071 C00001357 C00001431 C00001432 | 0 / 0 | 
| P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00000956 C00001071 C00001201 C00001357 C00008818 | 0 / 3 | 
| P00352 | Retinal dehydrogenase 1 | Enzyme | C00000956 C00001071 C00001357 C00003800 C00008818 | 0 / 0 | 
| P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00000956 C00001071 C00001183 C00001357 C00008818 | 0 / 0 | 
| P00915 | Carbonic anhydrase 1 | Lyase | C00000956 C00001183 C00001357 C00001431 C00001432 | 0 / 0 | 
| O75164 | Lysine-specific demethylase 4A | Enzyme | C00001071 C00001183 C00001201 C00001357 | 0 / 0 | 
| Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00001071 C00001357 C00001432 C00008818 | 1 / 4 | 
| O43570 | Carbonic anhydrase 12 | Lyase | C00000956 C00001357 C00001431 C00001432 | 1 / 2 | 
| Q13951 | Core-binding factor subunit beta | Unclassified protein | C00001071 C00001357 C00001432 C00008818 | 0 / 1 | 
| P22748 | Carbonic anhydrase 4 | Lyase | C00000956 C00001357 C00001431 C00001432 | 1 / 1 | 
| Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00000956 C00001071 C00001357 C00008818 | 1 / 1 | 
| O75496 | Geminin | Unclassified protein | C00001183 C00001201 C00001357 C00001518 | 0 / 0 | 
| Q16790 | Carbonic anhydrase 9 | Lyase | C00000956 C00001357 C00001431 C00001432 | 0 / 1 | 
| P11387 | DNA topoisomerase 1 | Isomerase | C00001071 C00005178 C00005184 C00005224 | 0 / 0 | 
| P23280 | Carbonic anhydrase 6 | Lyase | C00000956 C00001357 C00001431 C00001432 | 0 / 0 | 
| P43166 | Carbonic anhydrase 7 | Lyase | C00000956 C00001357 C00001431 C00001432 | 0 / 0 | 
| Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00000956 C00001071 C00001357 C00001432 | 1 / 2 | 
| Q9ULX7 | Carbonic anhydrase 14 | Lyase | C00000956 C00001357 C00001431 C00001432 | 0 / 0 | 
| P17252 | Protein kinase C alpha type | Alpha | C00000956 C00001357 C00002935 C00009075 | 0 / 0 | 
| Q9UBT6 | DNA polymerase kappa | Enzyme | C00000956 C00001071 C00001357 C00008818 | 0 / 0 | 
| P16473 | Thyrotropin receptor | Glycohormone receptor | C00000134 C00000956 C00001183 C00001431 | 3 / 2 | 
| P07451 | Carbonic anhydrase 3 | Lyase | C00000956 C00001357 C00001431 C00001432 | 0 / 0 | 
| O00255 | Menin | Unclassified protein | C00000956 C00001071 C00001357 C00001432 | 2 / 5 | 
| P39748 | Flap endonuclease 1 | Enzyme | C00000956 C00001071 C00001357 | 0 / 0 | 
| P41143 | Delta-type opioid receptor | Opioid receptor | C00000956 C00001357 C00008818 | 0 / 0 | 
| Q9Y253 | DNA polymerase eta | Enzyme | C00000956 C00001071 C00001357 | 1 / 1 | 
| O15296 | Arachidonate 15-lipoxygenase B | Enzyme | C00001071 C00001431 C00001432 | 0 / 0 | 
| Q9Y3R4 | Sialidase-2 | Enzyme | C00000956 C00001071 C00003800 | 0 / 0 | 
| Q15139 | Serine/threonine-protein kinase D1 | Pkd | C00000956 C00002935 C00009075 | 0 / 0 | 
| Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00000134 C00001183 C00001357 | 0 / 0 | 
| P83916 | Chromobox protein homolog 1 | Unclassified protein | C00001071 C00001183 C00001357 | 0 / 0 | 
| Q05655 | Protein kinase C delta type | Delta | C00000956 C00002935 C00009075 | 0 / 0 | 
| P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | C00000956 C00001071 C00008818 | 1 / 1 | 
| P40225 | Thrombopoietin | Unclassified protein | C00001071 C00001431 C00001432 | 1 / 1 | 
| P06746 | DNA polymerase beta | Enzyme | C00000956 C00001071 C00001357 | 0 / 0 | 
| Q05513 | Protein kinase C zeta type | Iota | C00000956 C00002935 C00009075 | 0 / 0 | 
| Q04759 | Protein kinase C theta type | Delta | C00000956 C00002935 C00009075 | 0 / 1 | 
| Q9UNA4 | DNA polymerase iota | Enzyme | C00000956 C00001071 C00001357 | 0 / 0 | 
| P41145 | Kappa-type opioid receptor | Opioid receptor | C00000956 C00001357 C00008818 | 0 / 0 | 
| Q02156 | Protein kinase C epsilon type | Eta | C00000956 C00002935 C00009075 | 0 / 0 | 
| O94806 | Serine/threonine-protein kinase D3 | Pkd | C00000956 C00002935 C00009075 | 0 / 0 | 
| P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00000956 C00001357 C00008818 | 0 / 0 | 
| P41743 | Protein kinase C iota type | Iota | C00000956 C00002935 C00009075 | 0 / 0 | 
| P35372 | Mu-type opioid receptor | Opioid receptor | C00000956 C00001357 C00008818 | 0 / 0 | 
| P24723 | Protein kinase C eta type | Eta | C00000956 C00002935 C00009075 | 1 / 0 | 
| P02768 | Serum albumin | Secreted protein | C00000102 C00000956 C00008818 | 0 / 0 | 
| P28482 | Mitogen-activated protein kinase 1 | Erk | C00000956 C00001357 C00003800 | 0 / 0 | 
| P54132 | Bloom syndrome protein | Enzyme | C00000956 C00001071 C00001357 | 1 / 2 | 
| P05771 | Protein kinase C beta type | Alpha | C00000956 C00002935 C00009075 | 0 / 0 | 
| P05129 | Protein kinase C gamma type | Alpha | C00000956 C00002935 C00009075 | 1 / 1 | 
| P21728 | D(1A) dopamine receptor | Dopamine receptor | C00001071 C00001357 C00001432 | 0 / 0 | 
| O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00000956 C00001071 C00008818 | 0 / 0 | 
| Q92887 | Canalicular multispecific organic anion transporter 1 | Unclassified protein | C00001071 C00001518 | 1 / 1 | 
| Q01453 | Peripheral myelin protein 22 | Unclassified protein | C00000956 C00001071 | 5 / 2 | 
| Q99700 | Ataxin-2 | Unclassified protein | C00001071 C00001357 | 1 / 1 | 
| Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00001183 C00001431 | 0 / 0 | 
| P56817 | Beta-secretase 1 | A1A | C00000956 C00008818 | 0 / 0 | 
| P00374 | Dihydrofolate reductase | Oxidoreductase | C00000956 C00008818 | 1 / 1 | 
| P10696 | Alkaline phosphatase, placental-like | Enzyme | C00000956 C00001071 | 0 / 1 | 
| P03372 | Estrogen receptor | NR3A1 | C00000134 C00001357 | 1 / 1 | 
| P08581 | Hepatocyte growth factor receptor | TK tyrosine-protein kinase MET subfamily | C00000956 C00008818 | 2 / 3 | 
| Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00000956 C00001071 | 0 / 0 | 
| P22303 | Acetylcholinesterase | Hydrolase | C00001071 C00001357 | 1 / 0 | 
| P23467 | Receptor-type tyrosine-protein phosphatase beta | Receptor tyrosine-protein phosphatase | C00002935 C00009075 | 0 / 0 | 
| P18433 | Receptor-type tyrosine-protein phosphatase alpha | Receptor tyrosine-protein phosphatase | C00002935 C00009075 | 0 / 0 | 
| P27338 | Amine oxidase [flavin-containing] B | Oxidoreductase | C00001357 C00003800 | 0 / 0 | 
| P18054 | Arachidonate 12-lipoxygenase, 12S-type | Enzyme | C00001071 C00001357 | 2 / 0 | 
| P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00001357 C00003800 | 1 / 1 | 
| P04745 | Alpha-amylase 1 | Enzyme | C00000956 C00001071 | 0 / 0 | 
| P11511 | Cytochrome P450 19A1 | Cytochrome P450 19A1 | C00001071 C00003800 | 2 / 2 | 
| Q16637 | Survival motor neuron protein | Unclassified protein | C00000956 C00003800 | 4 / 1 | 
| P52209 | 6-phosphogluconate dehydrogenase, decarboxylating | Enzyme | C00000956 C00008818 | 0 / 0 | 
| Q99549 | M-phase phosphoprotein 8 | Unclassified protein | C00001071 C00001357 | 0 / 0 | 
| O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | C00001071 C00001357 | 0 / 0 | 
| P10415 | Apoptosis regulator Bcl-2 | Other cytosolic protein | C00000956 C00008818 | 0 / 7 | 
| P05186 | Alkaline phosphatase, tissue-nonspecific isozyme | Enzyme | C00000956 C00001071 | 3 / 1 | 
| P06239 | Tyrosine-protein kinase Lck | Src | C00001357 C00003800 | 0 / 1 | 
| P09923 | Intestinal-type alkaline phosphatase | Enzyme | C00000956 C00001071 | 0 / 0 | 
| P28907 | ADP-ribosyl cyclase 1 | Enzyme | C00000956 C00001071 | 0 / 1 | 
| Q9H015 | Solute carrier family 22 member 4 | Unclassified protein | C00001431 C00001432 | 1 / 1 | 
| O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00001071 C00001357 | 0 / 0 | 
| Q14191 | Werner syndrome ATP-dependent helicase | Enzyme | C00001071 C00001357 | 2 / 1 | 
| P33527 | Multidrug resistance-associated protein 1 | drugs | C00001071 C00001518 | 0 / 0 | 
| Q04760 | Lactoylglutathione lyase | Enzyme | C00001071 C00001518 | 0 / 0 | 
| P42345 | Serine/threonine-protein kinase mTOR | Enzyme | C00001071 C00001431 | 0 / 0 | 
| Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00001071 C00001357 | 0 / 0 | 
| Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00001071 C00001357 | 0 / 0 | 
| P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00001357 | 1 / 1 | 
| P42330 | Aldo-keto reductase family 1 member C3 | Enzyme | C00000218 | 0 / 0 | 
| Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00001431 | 0 / 0 | 
| P07998 | Ribonuclease pancreatic | Enzyme | C00000956 | 0 / 0 | 
| P42858 | Huntingtin | Unclassified protein | C00001357 | 1 / 1 | 
| P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00000956 | 2 / 0 | 
| P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00001357 | 0 / 0 | 
| O15439 | Multidrug resistance-associated protein 4 | Unclassified protein | C00001518 | 0 / 0 | 
| P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00001357 | 0 / 0 | 
| P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00001357 | 0 / 0 | 
| P21917 | D(4) dopamine receptor | Dopamine receptor | C00001357 | 0 / 0 | 
| P30988 | Calcitonin receptor | Calcitonin receptor | C00001357 | 0 / 0 | 
| P35462 | D(3) dopamine receptor | Dopamine receptor | C00001357 | 1 / 0 | 
| P36888 | Receptor-type tyrosine-protein kinase FLT3 | Pdgfr | C00001071 | 1 / 1 | 
| Q92731 | Estrogen receptor beta | NR3A2 | C00001357 | 0 / 1 | 
| P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00001357 | 0 / 0 | 
| P15121 | Aldose reductase | Enzyme | C00001071 | 0 / 0 | 
| P25101 | Endothelin-1 receptor | Endothelin receptor | C00001357 | 0 / 0 | 
| P30411 | B2 bradykinin receptor | Bradykinin receptor | C00001357 | 0 / 0 | 
| P10145 | Interleukin-8 | Secreted protein | C00000134 | 0 / 0 | 
| P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00001357 | 1 / 0 | 
| P16581 | E-selectin | Adhesion | C00001201 | 0 / 0 | 
| Q14790 | Caspase-8 | C14 | C00001071 | 2 / 1 | 
| Q6QHF9 | Peroxisomal N(1)-acetyl-spermine/spermidine oxidase | Enzyme | C00001431 | 0 / 0 | 
| P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00001357 | 0 / 0 | 
| P08311 | Cathepsin G | S1A | C00001357 | 0 / 0 | 
| P07711 | Cathepsin L1 | C1A | C00000956 | 0 / 0 | 
| Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00001357 | 1 / 0 | 
| P09874 | Poly [ADP-ribose] polymerase 1 | Enzyme | C00003825 | 0 / 0 | 
| P03956 | Interstitial collagenase | M10A | C00001357 | 0 / 1 | 
| P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00001357 | 0 / 0 | 
| P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00001357 | 1 / 0 | 
| P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00001357 | 0 / 0 | 
| P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00001357 | 1 / 1 | 
| Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | C00001071 | 0 / 0 | 
| P11308 | Transcriptional regulator ERG | Unclassified protein | C00001183 | 1 / 2 | 
| P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00001357 | 0 / 0 | 
| Q15746 | Myosin light chain kinase, smooth muscle | Mlck | C00001071 | 1 / 1 | 
| Q9HC16 | DNA dC->dU-editing enzyme APOBEC-3G | Enzyme | C00001071 | 0 / 0 | 
| P42575 | Caspase-2 | C14 | C00001432 | 0 / 0 | 
| P00734 | Prothrombin | S1A | C00000956 | 4 / 2 | 
| P04150 | Glucocorticoid receptor | NR3C1 | C00001357 | 0 / 1 | 
| P06213 | Insulin receptor | TK tyrosine-protein kinase INSR subfamily | C00001071 | 5 / 4 | 
| P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00001357 | 2 / 0 | 
| P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00001357 | 0 / 0 | 
| P29274 | Adenosine receptor A2a | Adenosine receptor | C00001357 | 0 / 0 | 
| P14679 | Tyrosinase | Oxidoreductase | C00001357 | 4 / 2 | 
| P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00001357 | 0 / 0 | 
| P31645 | Sodium-dependent serotonin transporter | Serotonin | C00001357 | 2 / 0 | 
| P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00003800 | 5 / 3 | 
| P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00001357 | 5 / 9 | 
| P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00001357 | 1 / 0 | 
| Q16678 | Cytochrome P450 1B1 | Cytochrome P450 1B1 | C00001071 | 4 / 4 | 
| P21452 | Substance-K receptor | Neurokinin receptor | C00001357 | 0 / 0 | 
| P12931 | Proto-oncogene tyrosine-protein kinase Src | Src | C00001198 | 0 / 0 | 
| P06276 | Cholinesterase | Hydrolase | C00001071 | 0 / 0 | 
| P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00001357 | 0 / 0 | 
| P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00001357 | 3 / 0 | 
| P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00001357 | 0 / 0 | 
| P06280 | Alpha-galactosidase A | Enzyme | C00003800 | 1 / 1 | 
| Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00001357 | 0 / 0 | 
| P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00001357 | 0 / 0 | 
| P14416 | D(2) dopamine receptor | Dopamine receptor | C00001357 | 2 / 0 | 
| P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00001357 | 1 / 8 | 
| P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00001357 | 1 / 0 | 
| Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | C00001071 | 1 / 0 | 
| Q9HC97 | G-protein coupled receptor 35 | Kynurenic acid receptor | C00001071 | 0 / 0 | 
| P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00001357 | 2 / 1 | 
| Q9GZT9 | Egl nine homolog 1 | Enzyme | C00001183 | 1 / 1 | 
| Q12879 | Glutamate receptor ionotropic, NMDA 2A | NS | C00001432 | 0 / 0 | 
| Q05586 | Glutamate receptor ionotropic, NMDA 1 | NS | C00001432 | 1 / 0 | 
| Q9Y2Q3 | Glutathione S-transferase kappa 1 | Enzyme | C00001518 | 0 / 0 | 
| Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00001357 | 0 / 0 | 
| P06241 | Tyrosine-protein kinase Fyn | Src | C00001357 | 0 / 0 | 
| O75762 | Transient receptor potential cation channel subfamily A member 1 | Unclassified protein | C00000447 | 1 / 0 | 
| Q04828 | Aldo-keto reductase family 1 member C1 | Enzyme | C00000218 | 0 / 0 | 
| P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00001357 | 0 / 0 | 
| P49327 | Fatty acid synthase | Transferase | C00000956 | 0 / 0 | 
| O15217 | Glutathione S-transferase A4 | Enzyme | C00000447 | 0 / 0 | 
| Q9H2K2 | Tankyrase-2 | Enzyme | C00003825 | 0 / 0 | 
| O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00001357 | 0 / 0 | 
| P04798 | Cytochrome P450 1A1 | Cytochrome P450 1A1 | C00001071 | 0 / 0 | 
| P11309 | Serine/threonine-protein kinase pim-1 | Pim | C00001071 | 0 / 0 | 
| P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00001357 | 1 / 0 | 
| P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00001357 | 0 / 0 | 
| P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00001357 | 0 / 0 | 
| P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00001357 | 0 / 0 | 
| P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00001357 | 0 / 0 | 
| P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00001357 | 0 / 0 | 
| P25103 | Substance-P receptor | Neurokinin receptor | C00001357 | 0 / 0 | 
| P25105 | Platelet-activating factor receptor | PAF receptor | C00001357 | 0 / 0 | 
| P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00001357 | 0 / 0 | 
| P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00001357 | 0 / 0 | 
| P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00000956 | 0 / 0 | 
| Q02880 | DNA topoisomerase 2-beta | Isomerase | C00001071 | 0 / 0 | 
| Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00001357 | 1 / 0 | 
| P55210 | Caspase-7 | C14 | C00001357 | 0 / 0 | 
| P16109 | P-selectin | Adhesion | C00001201 | 1 / 0 | 
| P35367 | Histamine H1 receptor | Histamine receptor | C00001357 | 0 / 0 | 
| P25021 | Histamine H2 receptor | Histamine receptor | C00001357 | 0 / 0 | 
| P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00001357 | 0 / 0 | 
| P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00001357 | 0 / 1 | 
| Q15046 | Lysine--tRNA ligase | Enzyme | C00001071 | 2 / 1 | 
| Q6W5P4 | Neuropeptide S receptor | Neuropeptide receptor | C00000956 | 1 / 0 | 
| P52895 | Aldo-keto reductase family 1 member C2 | Enzyme | C00000218 | 1 / 0 | 
| P05091 | Aldehyde dehydrogenase, mitochondrial | Oxidoreductase | C00003800 | 1 / 1 | 
| P42574 | Caspase-3 | C14 | C00001432 | 0 / 0 | 
| P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00000956 | 5 / 1 | 
| P10828 | Thyroid hormone receptor beta | NR1A2 | C00001357 | 3 / 1 | 
| Q8TD43 | Transient receptor potential cation channel subfamily M member 4 | Unclassified protein | C00001432 | 1 / 1 | 
| P02545 | Prelamin-A/C | Unclassified protein | C00001518 | 11 / 10 | 
| P10275 | Androgen receptor | NR3C4 | C00000134 | 3 / 4 | 
| P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00001357 | 1 / 1 | 
| P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00001357 | 0 / 0 | 
| P30542 | Adenosine receptor A1 | Adenosine receptor | C00001357 | 0 / 0 | 
| Q07869 | Peroxisome proliferator-activated receptor alpha | NR1C1 | C00003800 | 0 / 0 | 
| P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00001357 | 0 / 0 | 
| Q8TDS4 | Hydroxycarboxylic acid receptor 2 | Hydroxycarboxylic acid receptor | C00001183 | 0 / 0 | 
| O95271 | Tankyrase-1 | Enzyme | C00003825 | 0 / 0 | 
| O15245 | Solute carrier family 22 member 1 | Drug uniporter | C00001357 | 0 / 0 | 
| Q8N1Q1 | Carbonic anhydrase 13 | Lyase | C00000956 | 0 / 0 | 
| P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00001357 | 0 / 0 | 
| O14746 | Telomerase reverse transcriptase | Enzyme | C00003825 | 5 / 5 | 
| P14780 | Matrix metalloproteinase-9 | M10A | C00001357 | 2 / 2 | 
| Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00003800 | 0 / 0 | 
| P27361 | Mitogen-activated protein kinase 3 | Erk | C00001357 | 0 / 0 | 
| P29466 | Caspase-1 | C14 | C00001357 | 0 / 0 | 
| P42336 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | Enzyme | C00001071 | 9 / 1 | 
| P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00000956 | 1 / 1 | 
| P04062 | Glucosylceramidase | Enzyme | C00001071 | 6 / 4 | 
| P46059 | Solute carrier family 15 member 1 | Dipeptide | C00001357 | 0 / 0 | 
| P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00001357 | 0 / 0 | 
| P61073 | C-X-C chemokine receptor type 4 | CXC chemokine receptor | C00001432 | 1 / 1 | 
| Q16539 | Mitogen-activated protein kinase 14 | p38 | C00001357 | 0 / 0 | 
| Q13093 | Platelet-activating factor acetylhydrolase | Enzyme | C00000956 | 3 / 0 | 
| P33765 | Adenosine receptor A3 | Adenosine receptor | C00001357 | 0 / 0 | 
| P08246 | Neutrophil elastase | S1A | C00001357 | 2 / 1 | 
| Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00001357 | 2 / 2 | 
| Q16798 | NADP-dependent malic enzyme, mitochondrial | Enzyme | C00001183 | 0 / 0 | 
| P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00001071 | 2 / 0 | 
| O94956 | Solute carrier organic anion transporter family member 2B1 | Unclassified protein | C00001198 | 0 / 0 | 
| P31941 | DNA dC->dU-editing enzyme APOBEC-3A | Enzyme | C00001071 | 0 / 0 | 
| Q9NZQ8 | Transient receptor potential cation channel subfamily M member 5 | Unclassified protein | C00001432 | 0 / 0 | 
| P17516 | Aldo-keto reductase family 1 member C4 | Enzyme | C00000218 | 1 / 0 | 
| P04637 | Cellular tumor antigen p53 | Transcription Factor | C00001183 | 7 / 37 | 
| Q96QA9 | Multidrug resistance associated protein | Unclassified protein | C00001518 | 0 / 0 | 
| Q05BR4 | SLC16A10 protein | Unclassified protein | C00001357 | 0 / 0 | 
| P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00000956 | 0 / 0 | 
| Q9H0H5 | Rac GTPase-activating protein 1 | Unclassified protein | C00000956 | 0 / 0 | 
| P22310 | UDP-glucuronosyltransferase 1-4 | Enzyme | C00000956 | 3 / 0 | 
| Q9C0B1 | Alpha-ketoglutarate-dependent dioxygenase FTO | Unclassified protein | C00001183 | 1 / 2 | 
| Q9HCT0 | Fibroblast growth factor 22 | Unclassified protein | C00001071 | 0 / 0 | 
| gene | gene name | gene description | KNApSAcK metabolite in interactions | 
|---|---|---|---|
| 596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 | C00000176
                          C00001071
                          C00001432
                          C00001518 | 
| 836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | C00000176
                          C00001071
                          C00001431
                          C00001518 | 
| 3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) | C00001071
                          C00001518
                          C00007247 | 
| 5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) | C00001071
                          C00001518
                          C00007247 | 
| 1244 | ABCC2, ABC30, CMOAT, DJS, MRP2, cMRP | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | C00001071
                          C00001518 | 
| 595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 | C00000176
                          C00001518 | 
| 153 | ADRB1, ADRB1R, B1AR, BETA1AR, RHR | adrenoceptor beta 1 | C00001431
                          C00001432 | 
| 331 | XIAP, API3, BIRC4, IAP-3, ILP1, MIHA, XLP2, hIAP-3, hIAP3 | X-linked inhibitor of apoptosis | C00001431
                          C00001518 | 
| 4843 | NOS2, HEP-NOS, INOS, NOS, NOS2A | nitric oxide synthase 2, inducible (EC:1.14.13.39) | C00001432
                          C00001518 | 
| 1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | C00000176
                          C00001071 | 
| 5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) | C00001432
                          C00001518 | 
| 3565 | IL4, BCGF-1, BCGF1, BSF-1, BSF1, IL-4 | interleukin 4 | C00001518
                          C00007247 | 
| 3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta | C00001518
                          C00007247 | 
| 2729 | GCLC, GCL, GCS, GLCL, GLCLC | glutamate-cysteine ligase, catalytic subunit (EC:6.3.2.2) | C00001518
                          C00007247 | 
| 5925 | RB1, OSRC, RB, p105-Rb, pRb, pp110 | retinoblastoma 1 | C00000176
                          C00001518 | 
| 7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 | C00000176
                          C00001518 | 
| 4363 | ABCC1, ABC29, ABCC, GS-X, MRP, MRP1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 | C00001071
                          C00001518 | 
| 891 | CCNB1, CCNB | cyclin B1 | C00000176
                          C00001071 | 
| 1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) | C00001518
                          C00007247 | 
| 581 | BAX, BCL2L4 | BCL2-associated X protein | C00001071
                          C00001518 | 
| 842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) | C00001071
                          C00001518 | 
| 1571 | CYP2E1, CPE1, CYP2E, P450-J, P450C2E | cytochrome P450, family 2, subfamily E, polypeptide 1 (EC:1.14.13.n7) | C00001518
                          C00007247 | 
| 1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) | C00001518
                          C00007247 | 
| 7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor | C00001071
                          C00001518 | 
| 5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A | C00001071
                          C00001518 | 
| 54205 | CYCS, CYC, HCS, THC4 | cytochrome c, somatic | C00001071
                          C00001518 | 
| 154 | ADRB2, ADRB2R, ADRBR, B2AR, BAR, BETA2AR | adrenoceptor beta 2, surface | C00001431
                          C00001432 | 
| 1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) | C00001071
                          C00001518 | 
| 142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) | C00001071
                          C00001518 | 
| 4780 | NFE2L2, NRF2 | nuclear factor, erythroid 2-like 2 | C00001071
                          C00001518 | 
| 4609 | MYC, MRTL, MYCC, bHLHe39, c-Myc | v-myc avian myelocytomatosis viral oncogene homolog | C00001071
                          C00001518 | 
| 4318 | MMP9, CLG4B, GELB, MANDP2, MMP-9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) | C00001071
                          C00001518 | 
| 3091 | HIF1A, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1, PASD8, bHLHe78 | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | C00001071
                          C00001518 | 
| 598 | BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS | BCL2-like 1 | C00000176
                          C00001518 | 
| 3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) | C00001071
                          C00001518 | 
| 5757 | PTMA, TMSA | prothymosin, alpha | C00001518 | 
| 3082 | HGF, DFNB39, F-TCF, HGFB, HPTA, SF | hepatocyte growth factor (hepapoietin A; scatter factor) | C00001071 | 
| 2203 | FBP1, FBP | fructose-1,6-bisphosphatase 1 (EC:3.1.3.11) | C00001071 | 
| 54583 | EGLN1, C1orf12, ECYT3, HIF-PH2, HIFPH2, HPH-2, HPH2, PHD2, SM20, ZMYND6 | egl-9 family hypoxia-inducible factor 1 (EC:1.14.11.29) | C00001071 | 
| 8505 | PARG, PARG99 | poly (ADP-ribose) glycohydrolase (EC:3.2.1.143) | C00001071 | 
| 1786 | DNMT1, ADCADN, AIM, CXXC9, DNMT, HSN1E, MCMT | DNA (cytosine-5-)-methyltransferase 1 (EC:2.1.1.37) | C00001071 | 
| 8000 | PSCA, PRO232 | prostate stem cell antigen | C00001071 | 
| 1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | C00001071 | 
| 1499 | CTNNB1, CTNNB, MRD19, armadillo | catenin (cadherin-associated protein), beta 1, 88kDa | C00001071 | 
| 23411 | SIRT1, SIR2L1 | sirtuin 1 | C00001071 | 
| 6513 | SLC2A1, DYT17, DYT18, DYT9, EIG12, GLUT, GLUT1, GLUT1DS, HTLVR, PED | solute carrier family 2 (facilitated glucose transporter), member 1 | C00001071 | 
| 1312 | COMT | catechol-O-methyltransferase (EC:2.1.1.6) | C00001071 | 
| 7153 | TOP2A, TOP2, TP2A | topoisomerase (DNA) II alpha 170kDa (EC:5.99.1.3) | C00001071 | 
| 9540 | TP53I3, PIG3 | tumor protein p53 inducible protein 3 | C00001071 | 
| 8626 | TP63, AIS, B(p51A), B(p51B), EEC3, KET, LMS, NBP, OFC8, RHS, SHFM4, TP53CP, TP53L, TP73L, p40, p51, p53CP, p63, p73H, p73L | tumor protein p63 | C00001071 | 
| 7161 | TP73, P73 | tumor protein p73 | C00001071 | 
| 8714 | ABCC3, ABC31, EST90757, MLP2, MOAT-D, MRP3, cMOAT2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 3 | C00001518 | 
| 10257 | ABCC4, EST170205, MOAT-B, MOATB, MRP4 | ATP-binding cassette, sub-family C (CFTR/MRP), member 4 | C00001518 | 
| 10057 | ABCC5, ABC33, EST277145, MOAT-C, MOATC, MRP5, SMRP, pABC11 | ATP-binding cassette, sub-family C (CFTR/MRP), member 5 | C00001518 | 
| 368 | ABCC6, ABC34, ARA, EST349056, GACI2, MLP1, MOAT-E, MOATE, MRP6, PXE, PXE1, URG7 | ATP-binding cassette, sub-family C (CFTR/MRP), member 6 | C00001518 | 
| 128 | ADH5, ADH-3, ADHX, FALDH, FDH, GSH-FDH, GSNOR | alcohol dehydrogenase 5 (class III), chi polypeptide (EC:1.1.1.1 1.1.1.284) | C00001518 | 
| 231 | AKR1B1, ADR, ALDR1, ALR2, AR | aldo-keto reductase family 1, member B1 (aldose reductase) (EC:1.1.1.21) | C00001518 | 
| 8574 | AKR7A2, AFAR, AFAR1, AFB1-AR1, AKR7 | aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) (EC:1.1.1.n11) | C00001518 | 
| 207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | C00001518 | 
| 57412 | AS3MT, CYT19 | arsenic (+3 oxidation state) methyltransferase (EC:2.1.1.137) | C00001518 | 
| 329 | BIRC2, API1, HIAP2, Hiap-2, MIHB, RNF48, c-IAP1, cIAP1 | baculoviral IAP repeat containing 2 | C00001518 | 
| 330 | BIRC3, AIP1, API2, CIAP2, HAIP1, HIAP1, MALT2, MIHC, RNF49, c-IAP2 | baculoviral IAP repeat containing 3 | C00001518 | 
| 648 | BMI1, FLVI2/BMI1, PCGF4, RNF51 | BMI1 polycomb ring finger oncogene | C00001518 | 
| 6364 | CCL20, CKb4, LARC, MIP-3-alpha, MIP-3a, MIP3A, SCYA20, ST38 | chemokine (C-C motif) ligand 20 | C00001518 | 
| 942 | CD86, B7-2, B7.2, B70, CD28LG2, LAB72 | CD86 molecule | C00001518 | 
| 994 | CDC25B | cell division cycle 25B (EC:3.1.3.48) | C00001518 | 
| 995 | CDC25C, CDC25, PPP1R60 | cell division cycle 25C (EC:3.1.3.48) | C00001518 | 
| 1080 | CFTR, ABC35, ABCC7, CF, CFTR/MRP, MRP7, TNR-CFTR, dJ760C5.1 | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49) | C00001518 | 
| 1270 | CNTF, HCNTF | ciliary neurotrophic factor | C00001518 | 
| 1031 | CDKN2C, INK4C, p18, p18-INK4C | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) | C00001071 | 
| 1565 | CYP2D6, CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, CYPIID6, P450-DB1, P450C2D, P450DB1 | cytochrome P450, family 2, subfamily D, polypeptide 6 (EC:1.14.14.1) | C00001518 | 
| 847 | CAT | catalase (EC:1.11.1.6) | C00001071 | 
| 397 | ARHGDIB, D4, GDIA2, GDID4, LYGDI, Ly-GDI, RAP1GN1, RhoGDI2 | Rho GDP dissociation inhibitor (GDI) beta | C00001071 | 
| 1649 | DDIT3, CEBPZ, CHOP, CHOP-10, CHOP10, GADD153 | DNA-damage-inducible transcript 3 | C00001518 | 
| 1673 | DEFB4A, BD-2, DEFB-2, DEFB102, DEFB2, DEFB4, HBD-2, SAP1 | defensin, beta 4A | C00001518 | 
| 1956 | EGFR, ERBB, ERBB1, HER1, PIG61, mENA | epidermal growth factor receptor (EC:2.7.10.1) | C00001518 | 
| 2056 | EPO, EP, MVCD2 | erythropoietin | C00001518 | 
| 14103 | C00001518 | ||
| 2495 | FTH1, FHC, FTH, FTHL6, PIG15, PLIF | ferritin, heavy polypeptide 1 (EC:1.16.3.1) | C00001518 | 
| 2534 | FYN, SLK, SYN, p59-FYN | FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2) | C00001518 | 
| 2597 | GAPDH, G3PD, GAPD | glyceraldehyde-3-phosphate dehydrogenase (EC:1.2.1.12) | C00001518 | 
| 4193 | MDM2, ACTFS, HDMX, hdm2 | MDM2 oncogene, E3 ubiquitin protein ligase | C00000176 | 
| 2730 | GCLM, GLCLR | glutamate-cysteine ligase, modifier subunit (EC:6.3.2.2) | C00001518 | 
| 2745 | GLRX, GRX, GRX1 | glutaredoxin (thioltransferase) (EC:1.8.4.1) | C00001518 | 
| 2936 | GSR | glutathione reductase (EC:1.8.1.7) | C00001518 | 
| 2937 | GSS, GSHS | glutathione synthetase (EC:6.3.2.3) | C00001518 | 
| 2938 | GSTA1, GST2, GSTA1-1, GTH1 | glutathione S-transferase alpha 1 (EC:2.5.1.18) | C00001518 | 
| 2939 | GSTA2, GST2, GSTA2-2, GTA2, GTH2 | glutathione S-transferase alpha 2 (EC:2.5.1.18) | C00001518 | 
| 2940 | GSTA3, GSTA3-3, GTA3 | glutathione S-transferase alpha 3 (EC:2.5.1.18) | C00001518 | 
| 2941 | GSTA4, GSTA4-4, GTA4 | glutathione S-transferase alpha 4 (EC:2.5.1.18) | C00001518 | 
| 2944 | GSTM1, GST1, GSTM1-1, GSTM1a-1a, GSTM1b-1b, GTH4, GTM1, H-B, MU, MU-1 | glutathione S-transferase mu 1 (EC:2.5.1.18) | C00001518 | 
| 2946 | GSTM2, GST4, GSTM, GSTM2-2, GTHMUS | glutathione S-transferase mu 2 (muscle) (EC:2.5.1.18) | C00001518 | 
| 2947 | GSTM3, GST5, GSTB, GSTM3-3, GTM3 | glutathione S-transferase mu 3 (brain) (EC:2.5.1.18) | C00001518 | 
| 2948 | GSTM4, GSTM4-4, GTM4 | glutathione S-transferase mu 4 (EC:2.5.1.18) | C00001518 | 
| 2950 | GSTP1, DFN7, FAEES3, GST3, GSTP, PI | glutathione S-transferase pi 1 (EC:2.5.1.18) | C00001518 | 
| 2952 | GSTT1 | glutathione S-transferase theta 1 (EC:2.5.1.18) | C00001518 | 
| 2954 | GSTZ1, GSTZ1-1, MAAI, MAI | glutathione S-transferase zeta 1 (EC:2.5.1.18 5.2.1.2) | C00001518 | 
| 3265 | HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1 | Harvey rat sarcoma viral oncogene homolog | C00001518 | 
| 3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 | C00001518 | 
| 3458 | IFNG, IFG, IFI | interferon, gamma | C00001518 | 
| 3586 | IL10, CSIF, GVHDS, IL-10, IL10A, TGIF | interleukin 10 | C00001518 | 
| 3596 | IL13, IL-13, P600 | interleukin 13 | C00001518 | 
| 2100 | ESR2, ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2 | estrogen receptor 2 (ER beta) | C00000176 | 
| 2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 | C00000176 | 
| 3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 | C00001518 | 
| 3684 | ITGAM, CD11B, CR3A, MAC-1, MAC1A, MO1A, SLEB6 | integrin, alpha M (complement component 3 receptor 3 subunit) | C00001518 | 
| 9817 | KEAP1, INrf2, KLHL19 | kelch-like ECH-associated protein 1 | C00001518 | 
| 9314 | KLF4, EZF, GKLF | Kruppel-like factor 4 (gut) | C00001518 | 
| 3932 | LCK, LSK, YT16, p56lck, pp58lck | lymphocyte-specific protein tyrosine kinase (EC:2.7.10.2) | C00001518 | 
| 4067 | LYN, JTK8, p53Lyn, p56Lyn | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog (EC:2.7.10.2) | C00001518 | 
| 5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) | C00001518 | 
| 5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) | C00001518 | 
| 1027 | CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1 | cyclin-dependent kinase inhibitor 1B (p27, Kip1) | C00000176 | 
| 4255 | MGMT | O-6-methylguanine-DNA methyltransferase (EC:2.1.1.63) | C00001518 | 
| 4313 | MMP2, CLG4, CLG4A, MMP-II, MONA, TBE-1 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) | C00001518 | 
| 4353 | MPO | myeloperoxidase (EC:1.11.2.2) | C00001518 | 
| 4790 | NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | C00001518 | 
| 1019 | CDK4, CMM3, PSK-J3 | cyclin-dependent kinase 4 (EC:2.7.11.22) | C00000176 | 
| 1728 | NQO1, DHQU, DIA4, DTD, NMOR1, NMORI, QR1 | NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) | C00001518 | 
| 11315 | PARK7, DJ-1, DJ1 | parkinson protein 7 | C00001518 | 
| 5163 | PDK1 | pyruvate dehydrogenase kinase, isozyme 1 (EC:2.7.11.2) | C00001518 | 
| 5444 | PON1, ESA, MVCD5, PON | paraoxonase 1 (EC:3.1.1.2 3.1.8.1 3.1.1.81) | C00001518 | 
| 5446 | PON3 | paraoxonase 3 (EC:3.1.1.2 3.1.8.1 3.1.1.81) | C00001518 | 
| 10891 | PPARGC1A, LEM6, PGC-1(alpha), PGC-1v, PGC1, PGC1A, PPARGC1 | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | C00001518 | 
| 5580 | PRKCD, MAY1, PKCD, nPKC-delta | protein kinase C, delta (EC:2.7.10.2 2.7.11.13) | C00001518 | 
| 10544 | PROCR, CCCA, CCD41, EPCR | protein C receptor, endothelial | C00001518 | 
| 4233 | MET, AUTS9, HGFR, RCCP2, c-Met | met proto-oncogene (EC:2.7.10.1) | C00001071 | 
| 55312 | RFK, RIFK | riboflavin kinase (EC:2.7.1.26) | C00001518 | 
| 6401 | SELE, CD62E, ELAM, ELAM1, ESEL, LECAM2 | selectin E | C00001518 | 
| 6415 | SEPW1, selW | selenoprotein W, 1 | C00001518 | 
| 9356 | SLC22A6, HOAT1, OAT1, PAHT, ROAT1 | solute carrier family 22 (organic anion transporter), member 6 | C00001518 | 
| 29986 | SLC39A2, 6A1, ETI-1, ZIP-2, ZIP2 | solute carrier family 39 (zinc transporter), member 2 | C00001518 | 
| 6520 | SLC3A2, 4F2, 4F2HC, 4T2HC, CD98, CD98HC, MDU1, NACAE | solute carrier family 3 (amino acid transporter heavy chain), member 2 | C00001518 | 
| 23657 | SLC7A11, CCBR1, xCT | solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 | C00001518 | 
| 6647 | SOD1, ALS, ALS1, IPOA, SOD, hSod1, homodimer | superoxide dismutase 1, soluble (EC:1.15.1.1) | C00001518 | 
| 6648 | SOD2, IPOB, MNSOD, MVCD6 | superoxide dismutase 2, mitochondrial (EC:1.15.1.1) | C00001518 | 
| 6667 | SP1 | Sp1 transcription factor | C00001518 | 
| 6670 | SP3, SPR2 | Sp3 transcription factor | C00001518 | 
| 6671 | SP4, HF1B, SPR-1 | Sp4 transcription factor | C00001518 | 
| 6772 | STAT1, CANDF7, ISGF-3, STAT91 | signal transducer and activator of transcription 1, 91kDa | C00001518 | 
| 6774 | STAT3, APRF, HIES | signal transducer and activator of transcription 3 (acute-phase response factor) | C00001518 | 
| 7097 | TLR2, CD282, TIL4 | toll-like receptor 2 | C00001518 | 
| 7099 | TLR4, ARMD10, CD284, TLR-4, TOLL | toll-like receptor 4 | C00001518 | 
| 8795 | TNFRSF10B, CD262, DR5, KILLER, KILLER/DR5, TRAIL-R2, TRAILR2, TRICK2, TRICK2A, TRICK2B, TRICKB, ZTNFR9 | tumor necrosis factor receptor superfamily, member 10b | C00001518 | 
| 7299 | TYR, ATN, CMM8, OCA1, OCA1A, OCAIA, SHEP3 | tyrosinase (EC:1.14.18.1) | C00001518 | 
| 7412 | VCAM1, CD106, INCAM-100 | vascular cell adhesion molecule 1 | C00001518 | 
| 7422 | VEGFA, MVCD1, VEGF, VPF | vascular endothelial growth factor A | C00001518 | 
| 1017 | CDK2, p33(CDK2) | cyclin-dependent kinase 2 (EC:2.7.11.22) | C00000176 | 
| 898 | CCNE1, CCNE | cyclin E1 | C00000176 | 
| 637 | BID, FP497 | BH3 interacting domain death agonist | C00000176 | 
| 486 | FXYD2, ATP1G1, HOMG2 | FXYD domain containing ion transport regulator 2 | C00001431 | 
| 846 | CASR, CAR, EIG8, FHH, FIH, GPRC2A, HHC, HHC1, HYPOC1, NSHPT, PCAR1 | calcium-sensing receptor | C00001432 | 
| 56616 | DIABLO, DFNA64, SMAC | diablo, IAP-binding mitochondrial protein | C00001432 | 
| 8647 | ABCB11, ABC16, BRIC2, BSEP, PFIC-2, PFIC2, PGY4, SPGP | ATP-binding cassette, sub-family B (MDR/TAP), member 11 | C00007247 | 
| 1374 | CPT1A, CPT1, CPT1-L, L-CPT1 | carnitine palmitoyltransferase 1A (liver) (EC:2.3.1.21) | C00007247 | 
| 1591 | CYP24A1, CP24, CYP24, HCAI, P450-CC24 | cytochrome P450, family 24, subfamily A, polypeptide 1 (EC:1.14.13.126) | C00007247 | 
| 1557 | CYP2C19, CPCJ, CYP2C, P450C2C, P450IIC19 | cytochrome P450, family 2, subfamily C, polypeptide 19 (EC:1.14.13.48 1.14.13.49 1.14.13.80) | C00007247 | 
| 1559 | CYP2C9, CPC9, CYP2C, CYP2C10, CYPIIC9, P450IIC9 | cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) | C00007247 | 
| 3992 | FADS1, D5D, FADS6, FADSD5, LLCDL1, TU12 | fatty acid desaturase 1 (EC:1.14.19.-) | C00007247 | 
| 3827 | KNG1, BDK, BK, KNG | kininogen 1 | C00007247 | 
| 9971 | NR1H4, BAR, FXR, HRR-1, HRR1, RIP14 | nuclear receptor subfamily 1, group H, member 4 | C00007247 | 
| 5465 | PPARA, NR1C1, PPAR, PPARalpha, hPPAR | peroxisome proliferator-activated receptor alpha | C00007247 | 
| 100136658 | C00007247 | ||
| 5467 | PPARD, FAAR, NR1C2, NUC1, NUCI, NUCII, PPARB | peroxisome proliferator-activated receptor delta | C00007247 | 
| 5468 | PPARG, CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma | peroxisome proliferator-activated receptor gamma | C00007247 | 
| 6256 | RXRA, NR2B1 | retinoid X receptor, alpha | C00007247 | 
| 7421 | VDR, NR1I1 | vitamin D (1,25- dihydroxyvitamin D3) receptor | C00007247 | 
| 26762 | HAVCR1, HAVCR, HAVCR-1, KIM-1, KIM1, TIM, TIM-1, TIM1, TIMD-1, TIMD1 | hepatitis A virus cellular receptor 1 | C00001198 | 
| OMIM | preferred title | UniProt | 
|---|---|---|
| #300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency | Q99714 | 
| #614279 | 46,xy sex reversal 8; srxy8 | P17516 P52895 | 
| #100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism | P20309 | 
| #202300 | Adrenocortical carcinoma, hereditary; adcc | P04637 | 
| #103470 | Albinism, ocular, with sensorineural deafness | P14679 | 
| #203100 | Albinism, oculocutaneous, type ia; oca1a | P14679 | 
| #606952 | Albinism, oculocutaneous, type ib; oca1b | P14679 | 
| #103780 | Alcohol dependence | P08172 P14416 P31645 | 
| #610251 | Alcohol sensitivity, acute | P05091 | 
| #614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 | Q99720 | 
| #300068 | Androgen insensitivity syndrome; ais | P10275 | 
| #312300 | Androgen insensitivity, partial; pais | P10275 | 
| #613780 | Aortic aneurysm, familial thoracic 7; aat7 | Q15746 | 
| #609135 | Aplastic anemia | O14746 | 
| #613546 | Aromatase deficiency | P11511 | 
| #139300 | Aromatase excess syndrome; aexs | P11511 | 
| #600807 | Asthma, susceptibility to | Q13093 | 
| #608584 | Asthma-related traits, susceptibility to, 2 | Q6W5P4 | 
| #614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 | P04637 | 
| #601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 | P22309 | 
| #210900 | Bloom syndrome; blm | P54132 | 
| #602025 | Body mass index quantitative trait locus 9; bmiq9 | P41968 | 
| %606641 | Body mass index; bmi | P37231 | 
| #114480 | Breast cancer | P42336 | 
| #300615 | Brunner syndrome | P21397 | 
| #115200 | Cardiomyopathy, dilated, 1a; cmd1a | P02545 | 
| #212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism | P02545 | 
| #609338 | Carotid intimal medial thickness 1 | P37231 | 
| #607271 | Caspase 8 deficiency | Q14790 | 
| #118300 | Charcot-marie-tooth disease and deafness | Q01453 | 
| #605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 | P02545 | 
| #118220 | Charcot-marie-tooth disease, demyelinating, type 1a; cmt1a | Q01453 | 
| #613641 | Charcot-marie-tooth disease, recessive intermediate b; cmtrib | Q15046 | 
| #114500 | Colorectal cancer; crc | P18054 P42336 P84022 Q14191 | 
| #612918 | Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi | P42336 | 
| #615108 | Cowden syndrome 5; cws5 | P42336 | 
| #218800 | Crigler-najjar syndrome, type i | P22309 P22310 | 
| #606785 | Crigler-najjar syndrome, type ii | P22309 P22310 | 
| #162800 | Cyclic neutropenia | P08246 | 
| #613916 | Deafness, autosomal recessive 89; dfnb89 | Q15046 | 
| #612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 | P51681 | 
| #610549 | Diabetes mellitus, insulin-resistant, with acanthosis nigricans | P06213 | 
| #125853 | Diabetes mellitus, noninsulin-dependent; niddm | P06213 | 
| #119900 | Digital clubbing, isolated congenital | P15428 | 
| #246200 | Donohue syndrome | P06213 | 
| #609535 | Drug metabolism, poor, cyp2c19-related | P33261 | 
| #608902 | Drug metabolism, poor, cyp2d6-related | P10635 | 
| #237500 | Dubin-johnson syndrome; djs | Q92887 | 
| #613989 | Dyskeratosis congenita, autosomal dominant, 2; dkca2 | O14746 | 
| #181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 | P02545 | 
| #615040 | Episodic pain syndrome, familial, 1; feps1 | O75762 | 
| #609820 | Erythrocytosis, familial, 3; ecyt3 | Q9GZT9 | 
| #133239 | Esophageal cancer | P04637 P18054 | 
| #615363 | Estrogen resistance; estrr | P03372 | 
| #612219 | Ewing sarcoma; es | P11308 | 
| #301500 | Fabry disease | P06280 | 
| #600274 | Frontotemporal dementia; ftd | P10636 | 
| #613659 | Gastric cancer | P04626 | 
| #137215 | Gastric cancer, hereditary diffuse; hdgc | P04626 | 
| #608013 | Gaucher disease, perinatal lethal | P04062 | 
| #230800 | Gaucher disease, type i | P04062 | 
| #230900 | Gaucher disease, type ii | P04062 | 
| #231000 | Gaucher disease, type iii | P04062 | 
| #231005 | Gaucher disease, type iiic | P04062 | 
| #231095 | Ghosal hematodiaphyseal dysplasia; ghdd | P24557 | 
| #143500 | Gilbert syndrome | P22309 P22310 | 
| #137750 | Glaucoma 1, open angle, a; glc1a | Q16678 | 
| #231300 | Glaucoma 3, primary congenital, a; glc3a | Q16678 | 
| #137760 | Glaucoma, primary open angle; poag | Q16678 | 
| #137800 | Glioma susceptibility 1; glm1 | P04626 P37231 | 
| #232300 | Glycogen storage disease ii | P10253 | 
| #612938 | Growth retardation, developmental delay, coarse facies, and early death; gdfd | Q9C0B1 | 
| #139393 | Guillain-barre syndrome, familial; gbs | Q01453 | 
| #605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay | Q03164 | 
| #610140 | Heart-hand syndrome, slovenian type | P02545 | 
| #114550 | Hepatocellular carcinoma | P08581 P42336 | 
| #609423 | Human immunodeficiency virus type 1, susceptibility to | P41597 P51681 | 
| #143100 | Huntington disease; hd | P42858 | 
| #176670 | Hutchinson-gilford progeria syndrome; hgps | P02545 | 
| #237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn | P22309 | 
| #143860 | Hyperchlorhidrosis, isolated | O43570 | 
| #609968 | Hyperinsulinemic hypoglycemia, familial, 5; hhf5 | P06213 | 
| #145000 | Hyperparathyroidism 1; hrpt1 | O00255 | 
| #603373 | Hyperthyroidism, familial gestational | P16473 | 
| #609152 | Hyperthyroidism, nonautoimmune | P16473 | 
| #145900 | Hypertrophic neuropathy of dejerine-sottas | Q01453 | 
| #259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 | P15428 | 
| #146300 | Hypophosphatasia, adult | P05186 | 
| #241510 | Hypophosphatasia, childhood | P05186 | 
| #241500 | Hypophosphatasia, infantile | P05186 | 
| #275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 | P16473 | 
| #147050 | Ige responsiveness, atopic; iger | Q13093 | 
| #603932 | Intervertebral disc disease; idd | P14780 | 
| #182000 | Keratosis, seborrheic | P42336 | 
| #601626 | Leukemia, acute myeloid; aml | P36888 | 
| #151623 | Li-fraumeni syndrome 1; lfs1 | P04637 | 
| #151660 | Lipodystrophy, familial partial, type 2; fpld2 | P02545 | 
| #604367 | Lipodystrophy, familial partial, type 3; fpld3 | P37231 | 
| #613795 | Loeys-dietz syndrome, type 3; lds3 | P84022 | 
| #613688 | Long qt syndrome 2; lqt2 | Q12809 | 
| #211980 | Lung cancer | P00533 P04626 P04637 Q14790 | 
| #608516 | Major depressive disorder; mdd | P08172 | 
| #248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada | P02545 | 
| #602501 | Megalencephaly-capillary malformation-polymicrogyria syndrome; mcap | P42336 | 
| #603387 | Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome; mpph | P42336 | 
| #613839 | Megaloblastic anemia due to dihydrofolate reductase deficiency | P00374 | 
| #615134 | Melanoma, cutaneous malignant, susceptibility to, 9; cmm9 | O14746 | 
| #614254 | Mental retardation, autosomal dominant 8; mrd8 | Q05586 | 
| #300705 | Mental retardation, x-linked 17; mrx17 | Q99714 | 
| %300852 | Mental retardation, x-linked 88; mrx88 | P50052 | 
| #300220 | Mental retardation, x-linked, syndromic 10; mrxs10 | Q99714 | 
| #613073 | Metaphyseal anadysplasia 2; mandp2 | P14780 | 
| #131100 | Multiple endocrine neoplasia, type i; men1 | O00255 | 
| #126200 | Multiple sclerosis, susceptibility to; ms | P08575 | 
| #613205 | Muscular dystrophy, congenital, lmna-related | P02545 | 
| #159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b | P02545 | 
| #607948 | Mycobacterium tuberculosis, susceptibility to | P11473 | 
| #159900 | Myoclonic dystonia | P14416 | 
| #160900 | Myotonic dystrophy 1; dm1 | Q9NR56 | 
| #162500 | Neuropathy, hereditary, with liability to pressure palsies; hnpp | Q01453 | 
| #202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 | P08246 | 
| #601665 | Obesity | P32245 P37231 | 
| #164230 | Obsessive-compulsive disorder; ocd | P31645 | 
| #604715 | Orthostatic intolerance | P23975 | 
| #259730 | Osteopetrosis, autosomal recessive 3; optb3 | P00918 | 
| #167000 | Ovarian cancer | P04626 P42336 | 
| #260500 | Papilloma of choroid plexus; cpp | P04637 | 
| #168600 | Parkinson disease, late-onset; pd | P04062 | 
| #260540 | Parkinson-dementia syndrome | P10636 | 
| #613135 | Parkinsonism-dystonia, infantile; pkdys | Q01959 | 
| #604229 | Peters anomaly | Q16678 | 
| #172700 | Pick disease of brain | P10636 | 
| #262190 | Pineal hyperplasia, insulin-resistant diabetes mellitus, and somatic abnormalities | P06213 | 
| #601399 | Platelet disorder, familial, with associated myeloid malignancy | Q01196 | 
| #614278 | Platelet-activating factor acetylhydrolase deficiency; pafad | Q13093 | 
| #614390 | Pregnancy loss, recurrent, susceptibility to, 2; rprgl2 | P00734 | 
| #604559 | Progressive familial heart block, type ib; pfhb1b | Q8TD43 | 
| #613679 | Prothrombin deficiency, congenital | P00734 | 
| #614742 | Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1; pfbmft1 | O14746 | 
| #178500 | Pulmonary fibrosis, idiopathic; ipf | O14746 | 
| #605074 | Renal cell carcinoma, papillary, 1; rccp1 | P08581 | 
| #607276 | Resting heart rate, variation in | P08588 | 
| #275210 | Restrictive dermopathy, lethal | P02545 | 
| #600852 | Retinitis pigmentosa 17; rp17 | P22748 | 
| #180300 | Rheumatoid arthritis; ra | Q9H015 | 
| #604906 | Schizophrenia 9; sczd9 | P49798 | 
| #181500 | Schizophrenia; sczd | P49798 | 
| #608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive | P08575 | 
| #609620 | Short qt syndrome 1; sqt1 | Q12809 | 
| #601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 | P14679 | 
| #313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 | P10275 | 
| #253300 | Spinal muscular atrophy, type i; sma1 | Q16637 | 
| #253550 | Spinal muscular atrophy, type ii; sma2 | Q16637 | 
| #253400 | Spinal muscular atrophy, type iii; sma3 | Q16637 | 
| #271150 | Spinal muscular atrophy, type iv; sma4 | Q16637 | 
| #605361 | Spinocerebellar ataxia 14; sca14 | P05129 | 
| #183090 | Spinocerebellar ataxia 2; sca2 | Q99700 | 
| #607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 | Q9NUW8 | 
| #275355 | Squamous cell carcinoma, head and neck; hnscc | P04637 | 
| #601367 | Stroke, ischemic | P00734 P16109 P24723 | 
| #601104 | Supranuclear palsy, progressive, 1; psnp1 | P10636 | 
| #187950 | Thrombocythemia 1; thcyt1 | P40225 | 
| #188050 | Thrombophilia due to thrombin defect; thph1 | P00734 | 
| #188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth | P10828 | 
| #274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth | P10828 | 
| #145650 | Thyroid hormone resistance, selective pituitary; prth | P10828 | 
| #190300 | Tremor, hereditary essential, 1; etm1 | P35462 | 
| #277440 | Vitamin d-dependent rickets, type 2a; vddr2a | P11473 | 
| #277700 | Werner syndrome; wrn | Q14191 | 
| #610379 | West nile virus, susceptibility to | P51681 | 
| #193670 | Whim syndrome | P61073 | 
| #278300 | Xanthinuria, type i | P47989 | 
| #278750 | Xeroderma pigmentosum, variant type; xpv | Q9Y253 | 
| #112100 | Yt blood group antigen | P22303 | 
| KEGG | name | UniProt | 
|---|---|---|
| H00033 | Adrenal carcinoma | O00255
                            (related) P04637 (related) | 
| H00034 | Carcinoid | O00255
                            (related) | 
| H00045 | Malignant islet cell carcinoma | O00255
                            (related) | 
| H00246 | Primary hyperparathyroidism | O00255
                            (related) | 
| H01102 | Pituitary adenomas | O00255
                            (related) | 
| H00764 | Cri du chat syndrome | O14746
                            (related) | 
| H01132 | Aplastic anemia (AA) | O14746
                            (related) | 
| H01299 | Idiopathic pulmonary fibrosis | O14746
                            (related) | 
| H00022 | Bladder cancer | O14746
                            (marker) P00533 (related) P04626 (related) P04637 (related) | 
| H00024 | Prostate cancer | O14746
                            (marker) P10275 (related) P11308 (related) | 
| H01302 | Hyperchlorhidrosis isolated (HCHLH) | O43570
                            (related) | 
| H00021 | Renal cell carcinoma | O43570
                            (marker) P04637 (marker) P08581 (related) Q16790 (marker) | 
| H01197 | Dihydrofolate reductase (DHFR) deficiency | P00374
                            (related) | 
| H00016 | Oral cancer | P00533
                            (related) P00533 (marker) P04637 (related) P04637 (marker) | 
| H00017 | Esophageal cancer | P00533
                            (related) P04637 (related) P04637 (marker) P35354 (related) | 
| H00018 | Gastric cancer | P00533
                            (related) P04626 (related) P04637 (related) P08581 (related) P10415 (related) | 
| H00028 | Choriocarcinoma | P00533
                            (related) P03956 (related) P04626 (related) P04637 (related) P10415 (related) | 
| H00030 | Cervical cancer | P00533
                            (related) P04626 (related) P10415 (related) | 
| H00042 | Glioma | P00533
                            (related) P00533 (marker) P04637 (related) P04637 (marker) | 
| H00055 | Laryngeal cancer | P00533
                            (related) P00533 (marker) P04637 (related) P04637 (marker) | 
| H00223 | Inherited thrombophilia | P00734
                            (related) | 
| H01254 | Congenital prothrombin deficiency | P00734
                            (related) | 
| H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) | P00918
                            (related) | 
| H00436 | Osteopetrosis | P00918
                            (related) | 
| H00264 | Charcot-Marie-Tooth disease (CMT) | P02545
                            (related) Q01453 (related) Q15046 (related) | 
| H00294 | Dilated cardiomyopathy (DCM) | P02545
                            (related) | 
| H00420 | Familial partial lipodystrophy (FPL) | P02545
                            (related) P37231 (related) | 
| H00563 | Emery-Dreifuss muscular dystrophy | P02545
                            (related) | 
| H00590 | Congenital muscular dystrophies (CMD/MDC) | P02545
                            (related) | 
| H00593 | Limb-girdle muscular dystrophy (LGMD) | P02545
                            (related) | 
| H00601 | Hutchinson-Gilford progeria syndrome | P02545
                            (related) | 
| H00663 | Restrictive dermopathy | P02545
                            (related) | 
| H00665 | Mandibuloacral dysplasia | P02545
                            (related) | 
| H01216 | Left ventricular noncompaction (LVNC) | P02545
                            (related) | 
| H00026 | Endometrial Cancer | P03372
                            (marker) P04626 (related) P04637 (related) Q92731 (marker) | 
| H00066 | Lewy body dementia (LBD) | P04062
                            (related) | 
| H00126 | Gaucher disease | P04062
                            (related) | 
| H00426 | Defects in the degradation of ganglioside | P04062
                            (related) | 
| H00810 | Progressive myoclonic epilepsy (PME) | P04062
                            (related) | 
| H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) | P04150
                            (related) P11511 (related) | 
| H00019 | Pancreatic cancer | P04626
                            (related) P04637 (related) P04637 (marker) | 
| H00027 | Ovarian cancer | P04626
                            (related) P04637 (related) P42336 (related) | 
| H00031 | Breast cancer | P04626
                            (related) P04626 (marker) P04637 (related) | 
| H00046 | Cholangiocarcinoma | P04626
                            (related) P04637 (related) P08581 (related) P35354 (related) | 
| H00004 | Chronic myeloid leukemia (CML) | P04637
                            (related) Q01196 (related) | 
| H00005 | Chronic lymphocytic leukemia (CLL) | P04637
                            (related) P10415 (related) P28907 (marker) | 
| H00006 | Hairy-cell leukemia | P04637
                            (related) | 
| H00008 | Burkitt lymphoma | P04637
                            (related) | 
| H00009 | Adult T-cell leukemia | P04637
                            (related) | 
| H00010 | Multiple myeloma | P04637
                            (related) | 
| H00013 | Small cell lung cancer | P04637
                            (related) P10415 (related) | 
| H00014 | Non-small cell lung cancer | P04637
                            (related) | 
| H00015 | Malignant pleural mesothelioma | P04637
                            (related) | 
| H00020 | Colorectal cancer | P04637
                            (related) P04637 (marker) | 
| H00025 | Penile cancer | P04637
                            (related) P04637 (marker) P14780 (related) P35354 (related) | 
| H00029 | Vulvar cancer | P04637
                            (related) | 
| H00032 | Thyroid cancer | P04637
                            (related) P37231 (related) | 
| H00036 | Osteosarcoma | P04637
                            (related) P08684 (marker) | 
| H00038 | Malignant melanoma | P04637
                            (related) P14679 (marker) | 
| H00039 | Basal cell carcinoma | P04637
                            (related) | 
| H00040 | Squamous cell carcinoma | P04637
                            (related) | 
| H00041 | Kaposi's sarcoma | P04637
                            (related) P10415 (related) | 
| H00044 | Cancer of the anal canal | P04637
                            (related) | 
| H00047 | Gallbladder cancer | P04637
                            (related) | 
| H00048 | Hepatocellular carcinoma | P04637
                            (related) | 
| H00881 | Li-Fraumeni syndrome | P04637
                            (related) | 
| H01007 | Choroid plexus papilloma | P04637
                            (related) | 
| H01071 | Acute alcohol sensitivity | P05091
                            (related) | 
| H00063 | Spinocerebellar ataxia (SCA) | P05129
                            (related) Q99700 (related) Q9NUW8 (related) | 
| H00213 | Hypophosphatasia | P05186
                            (related) | 
| H00719 | Leprechaunism | P06213
                            (related) | 
| H00942 | Rabson-Mendenhall syndrome | P06213
                            (related) | 
| H01228 | Insulin-resistant diabetes mellitus with acanthosis nigricans (IRAN) | P06213
                            (related) | 
| H01267 | Familial hyperinsulinemic hypoglycemia (HHF) | P06213
                            (related) | 
| H00093 | Combined immunodeficiencies (CIDs) | P06239
                            (related) | 
| H00125 | Fabry disease | P06280
                            (related) | 
| H00079 | Asthma | P07550
                            (related) | 
| H00100 | Neutropenic disorders | P08246
                            (related) | 
| H00091 | T-B+Severe combined immunodeficiencies (SCIDs) | P08575
                            (related) | 
| H00069 | Glycogen storage diseases (GSD) | P10253
                            (related) | 
| H00062 | Spinal and bulbar muscular atrophy (SBMA) | P10275
                            (related) | 
| H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) | P10275
                            (related) | 
| H00609 | 46,XY disorders of sex development (Other) | P10275
                            (related) | 
| H00054 | Nasopharyngeal cancer | P10415
                            (related) | 
| H00058 | Amyotrophic lateral sclerosis (ALS) | P10636
                            (related) | 
| H00077 | Progressive supranuclear palsy (PSP) | P10636
                            (related) | 
| H00078 | Frontotemporal lobar degeneration (FTLD) | P10636
                            (related) | 
| H00023 | Testicular cancer | P10696
                            (marker) | 
| H00249 | Thyroid hormone resistance syndrome | P10828
                            (related) | 
| H00035 | Ewing's sarcoma | P11308
                            (related) | 
| H00342 | Tuberculosis | P11473
                            (related) | 
| H00784 | Localized autosomal recessive hypotrichosis | P11473
                            (related) | 
| H01143 | Vitamin D-dependent rickets | P11473
                            (related) | 
| H00794 | Aromatase excess syndrome | P11511
                            (related) | 
| H01205 | Coumarin resistance | P11712
                            (related) | 
| H00168 | Oculocutaneous albinism (OCA) | P14679
                            (related) | 
| H00479 | Metaphyseal dysplasias | P14780
                            (related) | 
| H00457 | Primary hypertrophic osteoarthropathy (PHO) | P15428
                            (related) | 
| H01246 | Isolated congenital nail clubbing (ICNC) | P15428
                            (related) | 
| H00250 | Congenital nongoitrous hypothyroidism (CHNG) | P16473
                            (related) | 
| H01269 | Congenital hyperthyroidism | P16473
                            (related) | 
| H00548 | Brunner syndrome | P21397
                            (related) | 
| H00208 | Hyperbilirubinemia | P22309
                            (related) Q92887 (related) | 
| H00527 | Retinitis pigmentosa (RP) | P22748
                            (related) | 
| H01031 | Orthostatic intolerance (OI) | P23975
                            (related) | 
| H00490 | Diaphyseal dysplasia with anemia (Ghosal) | P24557
                            (related) | 
| H01171 | Poor drug metabolism (PM) | P33261
                            (related) | 
| H00003 | Acute myeloid leukemia (AML) | P36888
                            (related) Q01196 (related) Q01196 (marker) Q13951 (marker) | 
| H00409 | Type II diabetes mellitus | P37231
                            (related) Q9C0B1 (related) | 
| H00227 | Congenital amegakaryocytic thrombocytopenia (CAMT) | P40225
                            (marker) | 
| H00059 | Huntington's disease (HD) | P42858
                            (related) | 
| H00192 | Xanthinuria | P47989
                            (related) | 
| H00480 | Non-syndromic X-linked mental retardation | P50052
                            (related) Q99714 (related) | 
| H00094 | DNA repair defects | P54132
                            (related) | 
| H00296 | Defects in RecQ helicases | P54132
                            (related) Q14191 (related) | 
| H00097 | Chemokine receptor defect | P61073
                            (related) | 
| H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) | Q01196
                            (related) Q01196 (marker) Q03164 (related) Q03164 (marker) | 
| H00978 | Thrombocytopenia (THC) | Q01196
                            (related) | 
| H01296 | Hereditary neuropathy with liability to pressure palsies (HNPP) | Q01453
                            (related) | 
| H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) | Q03164
                            (related) | 
| H00408 | Type I diabetes mellitus | Q04759
                            (related) | 
| H00720 | Long QT syndrome | Q12809
                            (related) | 
| H00725 | Short QT syndrome | Q12809
                            (related) | 
| H00108 | Autoimmune lymphoproliferative syndromes (ALPS) | Q14790
                            (related) | 
| H00801 | Familial thoracic aortic aneurysm and dissection (TAAD) | Q15746
                            (related) | 
| H00455 | Spinal muscular atrophy (SMA) | Q16637
                            (related) | 
| H00612 | Primary open angle glaucoma | Q16678
                            (related) | 
| H01075 | Peters anomaly | Q16678
                            (related) | 
| H01159 | Anterior segment dysgenesis (ASD) | Q16678
                            (related) | 
| H01203 | Primary congenital glaucoma (PCG) | Q16678
                            (related) | 
| H01263 | Progressive cardiac conduction defect (PCCD) | Q8TD43
                            (related) | 
| H00658 | Syndromic X-linked mental retardation | Q99714
                            (related) | 
| H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency | Q99714
                            (related) | 
| H00926 | Growth retardation, developmental delay, coarse facies, and early death | Q9C0B1
                            (related) | 
| H00236 | Congenital polycythemia | Q9GZT9
                            (related) | 
| H00286 | Crohn's disease | Q9H015
                            (related) | 
| H00403 | Disorders of nucleotide excision repair | Q9Y253
                            (related) | 
| MESH or OMIM | name | KNApSAcK metabolite | 
|---|---|---|
| D012640 | Seizures | C00001518 C00001431 C00001432 | 
| D009336 | Necrosis | C00001518 C00001432 | 
| D006948 | Hyperkinesis | C00001431 C00001432 | 
| D058186 | Acute Kidney Injury | C00001518 C00001198 | 
| D009422 | Nervous System Diseases | C00001518 C00007247 | 
| D001930 | Brain Injuries | C00001432 C00007247 | 
| D008569 | Memory Disorders | C00001518 C00001432 | 
| D006331 | Heart Diseases | C00001518 C00001432 | 
| D064420 | Drug-Related Side Effects and Adverse Reactions | C00001518 C00007247 | 
| D056486 | Drug-Induced Liver Injury | C00001518 C00001431 | 
| D001745 | Urinary Bladder Diseases | C00001518 | 
| D002779 | Cholestasis | C00001518 | 
| D003072 | Cognition Disorders | C00001518 | 
| D003550 | Cystic Fibrosis | C00001518 | 
| D003556 | Cystitis | C00001518 | 
| D003877 | Dermatitis, Contact | C00001518 | 
| D017719 | Diabetic Foot | C00001518 | 
| D002294 | Carcinoma, Squamous Cell | C00001518 | 
| D001321 | Autistic Disorder | C00001518 | 
| D004487 | Edema | C00001518 | 
| D005076 | Exanthema | C00001518 | 
| D005199 | Fanconi Anemia | C00001518 | 
| D005234 | Fatty Liver | C00001518 | 
| D005334 | Fever | C00001518 | 
| D005767 | Gastrointestinal Diseases | C00001518 | 
| D000647 | Amnesia | C00001518 | 
| D006417 | Hematuria | C00001518 | 
| D006461 | Hemolysis | C00001518 | 
| D006470 | Hemorrhage | C00001518 | 
| D020138 | HYPERHOMOCYSTEINEMIA | C00001518 | 
| D006973 | Hypertension | C00001518 | 
| D006975 | Hypertension, Portal | C00001518 | 
| D006980 | Hyperthyroidism | C00001518 | 
| D007565 | Jaundice | C00001518 | 
| D007674 | Kidney Diseases | C00001518 | 
| D008105 | Liver Cirrhosis, Biliary | C00001518 | 
| D008106 | Liver Cirrhosis, Experimental | C00001518 | 
| D008113 | Liver Neoplasms | C00001518 | 
| D001943 | Breast Neoplasms | C00000176 | 
| D008630 | Mercury Poisoning | C00001518 | 
| D008708 | Methemoglobinemia | C00001518 | 
| D009069 | Movement Disorders | C00001518 | 
| D009008 | Abnormalities, Severe Teratoid | C00001518 | 
| D009203 | Myocardial Infarction | C00001071 | 
| D020258 | Neurotoxicity Syndromes | C00001518 | 
| D010051 | Ovarian Neoplasms | C00001518 | 
| D010523 | Peripheral Nervous System Diseases | C00001518 | 
| D005909 | Glioblastoma | C00001071 | 
| D013226 | Status Epilepticus | C00001518 | 
| D009202 | Cardiomyopathies | C00001518 | 
| D006332 | Cardiomegaly | C00001431 | 
| D002471 | Cell Transformation, Neoplastic | C00001183 | 
| D011041 | Poisoning | C00001431 | 
| D000740 | Anemia | C00001432 | 
| D011471 | Prostatic Neoplasms | C00000176 | 
| D002545 | Brain Ischemia | C00001432 | 
| D007859 | Learning Disorders | C00001432 | 
| D009410 | Nerve Degeneration | C00001432 | 
| D014202 | Tremor | C00001432 | 
| D003866 | Depressive Disorder | C00007247 | 
| D007249 | Inflammation | C00007247 | 
| D006959 | Hyperoxaluria | C00001198 | 
| D006960 | Hyperoxaluria, Primary | C00001198 | 
| D009397 | Nephrocalcinosis | C00001198 | 
| D053040 | Nephrolithiasis | C00001198 | 
| D051437 | Renal Insufficiency | C00001198 |